Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

This study will identify the level of serum Riboneuclease 1 in systemic lupus patients and compare between its level in lupus nephritis and non nephritis.

Eligibility criteria

Qualifiers

Adult patients (≥18 years old) with non lupus nephritis SLE diagnosed according to the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus .

Adult patients (≥18 years old) with Lupus Nephritis classified according to the 2018 ISN/RPS classification criteria.

Disqualifiers

Patients less than 18 years old

Patients with other autoimmune diseases

Active infection and malignancy

Pregnancy and lactation

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

128 Participants
are grouped into 2 trial groups

Locations

This trial has no locations

Sponsors and collaborators